Literature DB >> 21717147

A rare cause of pulmonary infiltrates one should be aware of: a case of daptomycin-induced acute eosinophilic pneumonia.

C Rether1, A Conen, M Grossenbacher, W C Albrich.   

Abstract

We report a 69-year-old patient who developed fever and dyspnea 3 weeks after the initiation of daptomycin therapy for spondylodiscitis with lumbar epidural and bilateral psoas abscesses due to ampicillin- and high-level-gentamicin-resistant Enterococcus faecium. There was profound hypoxia and the chest X-ray showed extensive patchy infiltrates bilaterally. A bronchoalveolar lavage revealed 30% eosinophils and results of microbiological studies were normal. Daptomycin-induced eosinophilic pneumonia was diagnosed and the patient rapidly improved after the discontinuation of daptomycin and a brief course of prednisone. Increased attention must be paid to this rare but serious side effect of daptomycin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21717147     DOI: 10.1007/s15010-011-0148-y

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  14 in total

Review 1.  Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia.

Authors:  Joshua Solomon; Marvin Schwarz
Journal:  Semin Respir Crit Care Med       Date:  2006-04       Impact factor: 3.119

2.  Eosinophilic pneumonia induced by daptomycin.

Authors:  Don Hayes; Michael I Anstead; Robert J Kuhn
Journal:  J Infect       Date:  2007-01-17       Impact factor: 6.072

3.  Daptomycin-induced pulmonary infiltrates with eosinophilia.

Authors:  Anita Shinde; Ali Seifi; Sallustio DelRe; Wesam H Moustafa Hussein; Jonathan Ohebsion
Journal:  J Infect       Date:  2008-12-01       Impact factor: 6.072

4.  Organizing pneumonia and pulmonary eosinophilic infiltration associated with daptomycin.

Authors:  Elizabeth Cobb; Robert C Kimbrough; Kenneth M Nugent; Michael P Phy
Journal:  Ann Pharmacother       Date:  2007-03-20       Impact factor: 3.154

5.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

6.  Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact.

Authors:  Jared A Silverman; Lawrence I Mortin; Andrew D G Vanpraagh; Tongchuan Li; Jeff Alder
Journal:  J Infect Dis       Date:  2005-05-05       Impact factor: 5.226

7.  [Possible daptomycin-induced organizing pneumonia].

Authors:  Turid Snekloth Søndergaard; Helga Schumacher; Kirsten Norup
Journal:  Ugeskr Laeger       Date:  2010-08-09

8.  Two cases of daptomycin-induced eosinophilic pneumonia and chronic pneumonitis.

Authors:  Yasir Lal; Aristides P Assimacopoulos
Journal:  Clin Infect Dis       Date:  2010-03-01       Impact factor: 9.079

Review 9.  Pre-clinical experience with daptomycin.

Authors:  P M Hawkey
Journal:  J Antimicrob Chemother       Date:  2008-11       Impact factor: 5.790

10.  Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus.

Authors:  Jared A Silverman; Nancy G Perlmutter; Howard M Shapiro
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

View more
  4 in total

1.  Experience with daptomycin daily dosing in ICU patients undergoing continuous renal replacement therapy.

Authors:  B Preiswerk; A Rudiger; J Fehr; N Corti
Journal:  Infection       Date:  2012-07-21       Impact factor: 3.553

Review 2.  Daptomycin-induced eosinophilic pneumonia - a systematic review.

Authors:  Priyasha Uppal; Kerry L LaPlante; Melissa M Gaitanis; Matthew D Jankowich; Kristina E Ward
Journal:  Antimicrob Resist Infect Control       Date:  2016-12-12       Impact factor: 4.887

3.  Daptomycin associated eosinophilic pneumonia: case report and differential diagnoses.

Authors:  Sijan Basnet; Niranjan Tachamo; Rashmi Dhital; Biswaraj Tharu
Journal:  J Community Hosp Intern Med Perspect       Date:  2018-06-12

4.  Daptomycin-induced Eosinophilic Pneumonia and a Review of the Published Literature.

Authors:  Yoshitsugu Higashi; Shigeki Nakamura; Yasuhiro Tsuji; Chika Ogami; Kaoru Matsumoto; Koyomi Kawago; Kotaro Tokui; Ryuji Hayashi; Ippei Sakamaki; Yoshihiro Yamamoto
Journal:  Intern Med       Date:  2017-11-01       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.